Pancreas transplantation in cross-match-positive recipients using cyclosporine- or tacrolimus-based immunosuppression.
Khwaja
K
K
Department of Surgery, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN 55455, USA.
Wijkstrom
M
M
Gruessner
A
A
Noreen
H
H
Sutherland
D E R
DE
Gruessner
R W
RW
D016572:Cyclosporine / Q000627:therapeutic use*; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology; D015999:Multivariate Analysis; D016035:Pancreas Transplantation / Q000276:immunology* / Q000401:mortality; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology; D015996:Survival Rate; D013601:T-Lymphocytes / Q000276:immunology*; D016559:Tacrolimus / Q000627:therapeutic use*; D017211:Treatment Failure; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus